Long-term efficacy, safety, and tolerability of valsartan and hydrochlorothiazide in patients with essential hypertension
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference26 articles.
1. Pharmacological profile of valsartan: A potent, orally active, non peptide antagonist of the angiotensin II AT1 receptor subtype;Criscione;Br J Pharmacol,1993
2. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: A comparative study of the efficacy and safety against amlodipine;Corea;Clin Pharmacol Ther,1996
3. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension. Efficacy and safety compared to placebo and enalapril;Holwerda;J Hypertens,1996
4. Valsartan, a new angiotensin II receptor antagonist: A double-blind study comparing the incidence of cough with lisinopril and hydrochlorothiazide;Benz;J Clin Pharmacol,1997
5. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: Efficacy and safety compared to hydrochlorothiazide;Hegner;Eur J Clin Pharmacol,1997
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Valsartan plus hydrochlorothiazide: a review of its use since its introduction;Expert Opinion on Pharmacotherapy;2011-07-06
2. Efficacy and safety of combination therapy using high- or low-dose hydrochlorothiazide with valsartan or other angiotensin-receptor blockers;Advances in Therapy;2005-05
3. Valsartan Abolishes Most of the Memory-Improving Effects of Intracerebroventricular Angiotensin II in Rats;Clinical and Experimental Hypertension;2005-01
4. Antihypertensive Efficacy of Angiotensin Receptor Blockers in Combination With Hydrochlorothiazide: A Review of the Factorial‐Design Studies;The Journal of Clinical Hypertension;2004-10
5. Clinical Experience With Angiotensin Receptor Blockers With Particular Reference to Valsartan;The Journal of Clinical Hypertension;2004-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3